10% Owner · TriSalus Life Sciences, Inc. · Common Stock
Side
C
Value
—
Shares
759.0K
Price
—
Executed
Jul 31, 2025
Disclosed
Apr 20, 2026
Disclosure timeline263 days from execution to publication · legal deadline 2 business days
Jul 31 executedApr 20, 2026 disclosed
TLSI · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Derivative conversion — administrative, little informational value
Relative size+5 / 25
No reported dollar value · 12.2% of prior position
Filing timing+15 / 15
Disclosed 187 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Frankenius Equity AB filed this Form 4 reporting a derivative conversion of TLSI on Jul 31, 2025. It became public on Apr 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
10% Owner
Frankenius Equity ABcik:0001988262
Issuer
TriSalus Life Sciences, Inc.cik:0001826667
Revision history · 0
No field has changed since this record was first ingested.
